Literature DB >> 9558032

Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps.

N Sakai1, M Tatsuta, R Hirasawa, H Iishi, M Baba, Y Yokota, F Ikeda.   

Abstract

Helicobacter pylori infection of the gastric mucosal surface was investigated in patients with hamartomatous fundic polyps or hyperplastic polyps and in patients without endoscopic evidence of disease (healthy subjects). Presence of H. pylori infection was determined by culture, histologic examination, and the endoscopic phenol red test. Adherence of H. pylori was evaluated with scanning electron microscopic examination of antral biopsy specimens. Both prevalence of H. pylori infection (P < 0.001) and H. pylori adherence (P < 0.05) were less in patients with hamartomatous fundic polyps than in healthy subjects and patients with hyperplastic polyps. However, the percentages of plasma cells in gastric mucosa that contained IgA and of gastric epithelial cells that expressed Lewis b did not differ significantly among the three groups. These findings suggest that defense mechanisms against the attachment of H. pylori other than IgA or Lewis b antigen are present in patients with hamartomarous fundic polyps.

Entities:  

Mesh:

Year:  1998        PMID: 9558032     DOI: 10.1023/a:1018814014139

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

Review 2.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

4.  Contribution of HLA-DQA gene to host's response against Helicobacter pylori.

Authors:  T Azuma; J Konishi; Y Tanaka; M Hirai; S Ito; T Kato; Y Kohli
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

5.  The gastro-duodenal epithelium in peptic ulceration.

Authors:  H W Steer
Journal:  J Pathol       Date:  1985-08       Impact factor: 7.996

6.  Gastric glycerolipid as a receptor for Campylobacter pylori.

Authors:  C A Lingwood; H Law; A Pellizzari; P Sherman; B Drumm
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

7.  Gastric hamartomatous polyps in the absence of familial polyposis coli.

Authors:  M Tatsuta; S Okuda; H Tamura; H Taniguchi
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps.

Authors:  O Varis; F Laxén; J Valle
Journal:  APMIS       Date:  1994-10       Impact factor: 3.205

10.  Endoscopic diagnosis of early gastric cancer by the endoscopic Congo red-methylene blue test.

Authors:  M Tatsuta; S Okuda; H Tamura; H Taniguchi
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

View more
  11 in total

Review 1.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

2.  CONVENTIONAL VIDEOENDOSCOPY CAN IDENTIFY HELICOBACTER PYLORI GASTRITIS?

Authors:  Alexandre Gomes; Thelma Larocca Skare; Manoel Alberto Prestes; Maiza da Silva Costa; Roberta Dombroski Petisco; Gabriela Piovezani Ramos
Journal:  Arq Bras Cir Dig       Date:  2016 Apr-Jun

3.  Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan.

Authors:  Michio Hongo; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2010-02-23       Impact factor: 7.527

4.  Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions.

Authors:  Rafiul Sameer Islam; Neal C Patel; Dora Lam-Himlin; Cuong C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

Review 5.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

6.  Predictive findings for Helicobacter pylori-uninfected, -infected and -eradicated gastric mucosa: validation study.

Authors:  Kazuhiro Watanabe; Naoyoshi Nagata; Ryo Nakashima; Etsuko Furuhata; Takuro Shimbo; Masao Kobayakawa; Toshiyuki Sakurai; Koh Imbe; Ryota Niikura; Chizu Yokoi; Junichi Akiyama; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

7.  Regression of fundic gland polyps following acquisition of Helicobacter pylori.

Authors:  N Watanabe; H Seno; T Nakajima; S Yazumi; S Miyamoto; S Matsumoto; T Itoh; C Kawanami; K Okazaki; T Chiba
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

8.  Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.

Authors:  S Nakamura; T Matsumoto; Y Kobori; M Iida
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

10.  Benign gastric polyps: morphological and functional origin.

Authors:  Kurt Borch; John Skarsgård; Lennart Franzén; Sven Mårdh; Jens F Rehfeld
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.